DiaMedica Therapeutics Inc. (DMAC) stock
DMACNasdaqPharmaceutical PreparationsFiscal year ends December 31
$9.66−0.01 (-0.10%)
Close on Nov 11, 2026Market cap $520.92MP/E –Yield –
DiaMedica Therapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
DiaMedica Therapeutics's profit margin for the twelve months ending Dec 31, 2018 was -1146.8%. For fiscal 2018 it was -1146.8%.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | -1146.8% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2018 | Sep 30, 2018 | -277.4% | – |
See a number that looks wrong?